Recent studies seem to have shown that the consumption of green tea reduces the risk of ovarian and colorectal cancers.
While many studies have revealed the properties of green tea as being an anti-oxidant, protector of the liver, a great detoxifying agent, and a guardian of the cardiovascular system, two recent studies seems to have shown that green tea is also a powerful agent in the prevention and cure of cancers.
In a study conducted by the Fred Hutchinson Cancer Research Center in Seattle among some 781 ladies diagnosed with epithelial ovarian cancer between 2002 and 2005, in-person interviews have indicated that women who reported drinking green teas had a 54% reduction in risk of ovarian cancer.
Meanwhile, research personnel from the Fourth Military Medical University in Xi'an , China have reported movement in identifying the underlying mechanism by which green tea possesses therapeutic cancer effects through induction of apoptosis (programmed cell death) in colorectal cancer. Two different lines of colorectal cancer cells were treated with different concentrations of green tea, which led to repression of cell proliferation and induction of apoptosis in both cell lines.
The results of these studies seem to have suggested that green tea may also be a factor for inducing apoptosis in breast cells and endometrial cells, thereby acting as both a preventative and a factor in the cure for these cancers.
In addition to protecting against cancers, green tea lowers cholesterol levels, and reduces the clotting tendency of blood.
In addition to brewing and drinking green tea, there are green tea supplements available. Some of these contain the whole plant, while others contain extracts. Whole plant supplements are usually preferable because they are backed by the integrity of the whole plant. Many green tea supplements are standardized to provide a quantifiable amount of EGCG, viewed as its most beneficial component.
No comments:
Post a Comment